These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35078507)

  • 1. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
    Yin L; Li Q; Mrdenovic S; Chu GC; Wu BJ; Bu H; Duan P; Kim J; You S; Lewis MS; Liang G; Wang R; Zhau HE; Chung LWK
    Breast Cancer Res; 2022 Jan; 24(1):7. PubMed ID: 35078507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.
    Li Q; Yin L; Jones LW; Chu GC; Wu JB; Huang JM; Li Q; You S; Kim J; Lu YT; Mrdenovic S; Wang R; Freeman MR; Garraway I; Lewis MS; Chung LW; Zhau HE
    Oncotarget; 2016 Dec; 7(51):84645-84657. PubMed ID: 27835867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.
    Holen I; Whitworth J; Nutter F; Evans A; Brown HK; Lefley DV; Barbaric I; Jones M; Ottewell PD
    Breast Cancer Res; 2012 May; 14(3):R86. PubMed ID: 22632416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling.
    Peng F; Yang C; Kong Y; Huang X; Chen Y; Zhou Y; Xie X; Liu P
    Curr Cancer Drug Targets; 2020; 20(2):156-165. PubMed ID: 31744448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of RRS1 in breast cancer cells metastasis and AEG-1/AKT/c-Myc signaling pathway.
    He J; Liu S; Luo S; Fu J; Liao Z; Song J; Guo J; Hua Y
    Neoplasma; 2024 Aug; 71(4):347-358. PubMed ID: 39267538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway.
    Chen YJ; Lee LY; Chao YK; Chang JT; Lu YC; Li HF; Chiu CC; Li YC; Li YL; Chiou JF; Cheng AJ
    PLoS One; 2013; 8(5):e64088. PubMed ID: 23737966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.
    Sang Y; Sun L; Wu Y; Yuan W; Liu Y; Li SW
    Int J Oncol; 2019 Mar; 54(3):1112-1122. PubMed ID: 30628670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.
    Liu S; Cadaneanu RM; Zhang B; Huo L; Lai K; Li X; Galet C; Grogan TR; Elashoff D; Freedland SJ; Rettig M; Aronson WJ; Knudsen BS; Lewis MS; Garraway IP
    PLoS One; 2016; 11(10):e0163232. PubMed ID: 27711225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.
    Luo P; Zhang C; Liao F; Chen L; Liu Z; Long L; Jiang Z; Wang Y; Wang Z; Liu Z; Miao H; Shi C
    Cell Commun Signal; 2019 Apr; 17(1):36. PubMed ID: 30992017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival.
    Lu L; Zeng H; Gu X; Ma W
    Breast Cancer Res Treat; 2015 Jun; 151(3):491-500. PubMed ID: 25957595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plakoglobin restores tumor suppressor activity of p53
    Alaee M; Nool K; Pasdar M
    Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.
    Zhang C; Xu B; Lu S; Zhao Y; Liu P
    Mol Cancer; 2017 May; 16(1):90. PubMed ID: 28490334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.
    Ali A; Shafarin J; Muhammad JS; Farhat NM; Hamad M; Soofi A; Hamad M
    Cell Signal; 2023 Apr; 104():110591. PubMed ID: 36627007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
    Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
    Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PYCR2, induced by c-Myc, promotes the invasiveness and metastasis of breast cancer by activating AKT signalling pathway.
    Wu G; Qin S; Gu K; Zhou Y
    Int J Biochem Cell Biol; 2024 Jan; 166():106506. PubMed ID: 38101533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential estradiol and selective estrogen receptor modulator (SERM) regulation of Keratin 13 gene expression and its underlying mechanism in breast cancer cells.
    Sheng S; Barnett DH; Katzenellenbogen BS
    Mol Cell Endocrinol; 2008 Dec; 296(1-2):1-9. PubMed ID: 18951949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
    Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.